Canopy Growth (CGC) Non-Current Assets (2017 - 2026)

Canopy Growth (CGC) reported Non-Current Assets of $429.7 million for Q1 2026, down 1.05% on a YoY basis from $434.3 million in Q1 2025, and down 38.53% sequentially from $699.0 million in Q4 2025.

Canopy Growth (CGC) Non-Current Assets (2017 - 2026) Analysis & Trends

Canopy Growth (CGC) has 10 years of Non-Current Assets data on file, last reported at $429.7 million in Q1 2026.

  • For the quarter ending Q1 2026, Non-Current Assets fell 1.05% year-over-year to $429.7 million; the trailing twelve-month figure through Mar 2026 stood at $2.0 billion (down 18.0% YoY), and the FY2026 full-year result was $429.7 million, down 1.05% from the prior year.
  • Non-Current Assets declined to $429.7 million in Q1 2026, from $699.0 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $3.1 billion in Q1 2022 to a low of $429.7 million in Q1 2026.
  • A 5-year average of $941.3 million and a median of $707.0 million in 2023 frame the typical range for Non-Current Assets.
  • Across the five-year window, Non-Current Assets slumped 67.08% in 2023 and gained 3.16% in 2024, its largest moves.
  • Tracing CGC's Non-Current Assets over 5 years: stood at $1.3 billion in 2022, then tumbled by 46.38% to $707.0 million in 2023, then climbed by 3.16% to $729.3 million in 2024, then decreased by 4.16% to $699.0 million in 2025, then tumbled by 38.53% to $429.7 million in 2026.
  • Business Quant data shows CGC's Non-Current Assets at $429.7 million in Q1 2026, $699.0 million in Q4 2025, and $453.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 36.78 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 26.33 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 8.68 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 79.20 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 3.84 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 15.70 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 25.92 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 2.47 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 9.64 Bn
10 Canopy Growth 197.77 Mn -68.15 Mn - 429.70 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 429.70 Mn
Dec 31, 2025 699.03 Mn
Sep 30, 2025 453.44 Mn
Jun 30, 2025 433.97 Mn
Mar 31, 2025 434.27 Mn
Dec 31, 2024 729.34 Mn
Sep 30, 2024 616.27 Mn
Jun 30, 2024 678.82 Mn
Mar 31, 2024 689.53 Mn
Dec 31, 2023 706.97 Mn
Sep 30, 2023 876.12 Mn
Jun 30, 2023 973.23 Mn
Mar 31, 2023 1.01 Bn
Dec 31, 2022 1.32 Bn
Sep 30, 2022 1.39 Bn
Jun 30, 2022 1.51 Bn
Mar 31, 2022 3.06 Bn
Dec 31, 2021 3.43 Bn
Sep 30, 2021 3.17 Bn
Jun 30, 2021 3.49 Bn